Bioventix (LON:BVXP) Stock Price Passes Below 50 Day Moving Average - Should You Sell?

Key Points

• Bioventix PLC stock price fell below its fifty-day moving average of GBX 2,549.92, trading as low as GBX 2,448.13 on Monday.
• The company's market capitalization stands at £126.71 million, with a P/E ratio of 1,637.19, indicating a potentially overvalued stock.
• Bioventix specializes in creating and supplying sheep monoclonal antibodies for various diagnostic applications, including offerings for thyroid, vitamin D, and oncology.

Bioventix PLC (LON:BVXP - ) crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 2,549.92 ($34.69) and traded as low as GBX 2,448.13 ($33.30). Bioventix shares last traded at GBX 2,500 ($34.01), with a volume of 16,051 shares changing hands.

Bioventix Price Performance

The firm's 50-day moving average is GBX 2,549.92 and its 200-day moving average is GBX 2,647.35. The company has a market capitalization of £126.71 million, a P/E ratio of 1,637.19 and a beta of 0.35.

About Bioventix

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.